Vimarsana
Biggest News Aggregation in the World

Sandeep Eswarappa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sandeep Eswarappa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sandeep Eswarappa Today - Breaking & Trending Today

Study claims asthma drug can help fight COVID-19 - Vimarsana News

Study claims asthma drug can help fight COVID-19

Montelukast has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever, and hives

This asthma drug is capable of blocking coronavirus from replicating [details] - Vimarsana News

This asthma drug is capable of blocking coronavirus from replicating [details]

Montelukast has been approved by the US Food and Drug Administration for more than 20 years and is generally recommended to relieve inflammation caused by asthma

Asthma drug found to block coronavirus from replicating: IISc Bengaluru study - Vimarsana News

Asthma drug found to block coronavirus from replicating: IISc Bengaluru study

Asthma drug found to block coronavirus from replicating: IISc Bengaluru study - A study conducted by IISc Bengaluru shows that a drug used to treat asthma can help block SARS-CoV-2 protein from replicating.

Indian scientists indicate that antiallergic drug Montelukast can help treat Covid-19 - Vimarsana News

Indian scientists indicate that antiallergic drug Montelukast can help treat Covid-19

An antiallergic drug named Montelukast, which is commonly used to treat asthma, hay fever and hives, can be helpful in managing Covid-19 infection, researchers at the Indian Institute of Science (IISc) have indicated.

Asthma drug can block crucial SARS-CoV-2 protein: IISc study - Vimarsana News

Asthma drug can block crucial SARS-CoV-2 protein: IISc study

A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science ...